Fatal Strongyloides stercoralis hyper-infection in a patient with multiple myeloma

被引：10

作者：

Yassin, Mohamed A. ^{[1
]}

El Omri, Halima ^{[1
]}

Al-Hijji, Ibrahim ^{[1
]}

Taha, Ruba ^{[1
]}

Hassan, Reham ^{[1
]}

Al Aboudi, Kamal ^{[1
]}

El-Ayoubi, Hanadi ^{[1
]}

机构：

[1] Al Amal Hosp, Dept Hematol, Doha, Qatar

来源：

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES | 2010年 / 14卷 / 05期

关键词：

acute respiratory failure; disseminated strongyloidiasis; myeloma; steroids; IVERMECTIN;

D O I：

10.1590/S1413-86702010000500019

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Strongyloides stercoralis (S. S.) is a human intestinal parasite, which may lead to complicated strongyloidiasis. We report a case of disseminated strongyloidiasis following the treatment of myeloma. The patient developed skin lesions, respiratory distress, aseptic meningitis and bacterial and fungal sepsis. The diagnosis of strongyloidiasis was established through endotracheal tube secretions. Despite the treatment with Ivermectin and Albendazole, the outcome was fatal. The value of screening for strongyloidiasis is unclear but may be of benefit in patients with hematological malignancies from high endemic areas.

引用

收藏

页码：536 / 539

页数：4

相关论文

共 14 条

[1] Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis [J].

Carvalho, EM ;

Porto, AD .

PARASITE IMMUNOLOGY, 2004, 26 (11-12) :487-497

[2] Intestinal strongyloidiasis - Recognition, management, and determinants of outcome [J].

Concha, R ;

Harrington, W ;

Rogers, AI .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (03) :203-211

[3]

GENTA RM, 1989, REV INFECT DIS, V11, P755

[4] Dissemination of strongyloides stercoralis in a patient with systemic lupus erythematosus after initiation of albendazole: A case report [J].

Hunter C.J. ;

Petrosyan M. ;

Asch M. .

Journal of Medical Case Reports, 2 (1)

[5] Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis [J].

Igual-Adell, R ;

Oltra-Alcaraz, C ;

Soler-Company, E ;

Sánchez-Sánchez, P ;

Matogo-Oyana, J ;

Rodríguez-Calabuig, D .

EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (12) :2615-2619

[6] Strongyloides stercoralis in the immunocompromised population [J].

Keiser, PB ;

Nutman, TB .

CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (01) :208-+

[7] Complicated and fatal Strongyloides infection in Canadians:: risk factors, diagnosis and management [J].

Lim, S ;

Katz, K ;

Krajden, S ;

Fuksa, M ;

Keystone, AS ;

Kain, KC .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (05) :479-484

[8] The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States [J].

Muennig, P ;

Pallin, D ;

Challah, C ;

Khan, K .

EPIDEMIOLOGY AND INFECTION, 2004, 132 (06) :1055-1063

[9] Pulmonary strongyloidiasis in a patient receiving prednisolone therapy [J].

Namisato, S ;

Motomura, K ;

Haranaga, S ;

Hirata, T ;

Toyama, M ;

Shinzato, T ;

Higa, F ;

Saito, A .

INTERNAL MEDICINE, 2004, 43 (08) :731-736

[10] Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis [J].

Newberry, AM ;

Williams, DN ;

Stauffer, WM ;

Boulware, DR ;

Hendel-Paterson, BR ;

Walker, PF .

CHEST, 2005, 128 (05) :3681-3684